Developer docs
API playgroundTry for free, no card

Search company profiles

Amphasys

Full company profile

uuid000ba2v

Namestring
Amphasys
Legal namestring
Amphasys AG
Websiteurl
amphasys.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Amphasys AG is a Swiss specialty instrument company, founded in 2012 and headquartered at Technopark Lucerne, that develops and manufactures impedance flow cytometry (IFC) platforms for label-free, real-time single-cell analysis. Its core technology characterizes cells as they pass through microfluidic channels under alternating electrical fields, measuring cell size, membrane integrity, cytoplasmic conductivity, and metabolic status without dyes, markers, or calibration. The product line consists of three analyzers — the Ampha Z40 (stationary instrument for pollen and cells larger than 50 μm), the Ampha X30 (stationary instrument optimized for 1–50 μm cells in bioprocessing), and the Ampha P20 (portable battery-powered field analyzer) — supported by AmphaSoft PRO analysis software, patented microfluidic consumable chips (universal and crop-specific variants covering 250+ plant species), and AmphaFluid buffer solutions.

The company sells primarily to enterprise customers in the plant breeding and seed production industry (BASF, Bayer, Corteva, Syngenta, Rijk Zwaan, KWS, Bejo, Enza Zaden, Lidea Seeds, PanAmerican Seed), with growing penetration into industrial bioprocessing and food technology applications (Nestlé, Bühler, Doppelleu, Planet A Foods, edete Precision Technologies, Dropcopter) and academic research (University of Salzburg, University of Virginia, EPFL, RWTH Aachen). Revenue is generated through a mix of hardware sales, recurring consumable chip revenue, software, and service contracts, distributed via direct enterprise sales complemented by a global regional distributor network across Europe, North America, South America, Australia, and Africa.

Pricing is quote-based rather than publicly disclosed, consistent with enterprise sales of capital equipment plus multi-year service agreements. The company holds ISO 9001:2015 certification, supports 21 CFR Part 11-compliant workflows on the Ampha X30, and maintains community engagement through its annual Amphacademy symposium, which has run annually since 2017. No external equity funding rounds are disclosed, with only non-dilutive participation in MassChallenge (2020) and Technopark Luzern (2017) recorded, indicating an organic, self-funded growth profile across roughly 13 years of operation.

Short descriptiontext

Amphasys AG, founded 2012 in Lucerne, Switzerland, develops impedance flow cytometry instruments for label-free single-cell analysis, serving plant breeding and seed production enterprises as well as bioprocessing and food technology customers with hardware, consumable chips, and software.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLucerne, Switzerland
HQ citystring
Lucerne
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
impedance flow cytometry, label-free cell analysis, pollen viability testing, bioprocess monitoring, single-cell analysis instruments
Industry3 codes
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
SECONDARYHLAAAJAC
Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Analytical Laboratory Instruments
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Hardware Sales - Impedance Flow Cytometers
TypeHardware Sales
Description

Sale of Ampha X30, Ampha Z40, and Ampha P20 instruments - the core impedance flow cytometry hardware platforms for cell and pollen analysis.

amphasys.com
2Microfluidic Chips (AmphaChip)
TypeUsage Based
Description

Recurring consumable revenue from universal and crop-specific microfluidic chips. Universal chips come in 4 sizes; crop-specific chips available for major crops. Each chip provides 1000 measurements.

amphasys.com
3Software Licenses and Subscriptions
TypeSubscription Recurring
Description

AmphaSoft PRO software for data analysis. The software is integrated with the instrument platform and supports both automated routine analysis and in-depth research analysis.

amphasys.com
4Support and Maintenance Contracts
TypeManaged Services
Description

Annual support and maintenance plans for instruments including software updates, technical support, and calibration services. Separate service contracts available for Ampha P20 and Ampha Z32/Z40 instruments.

amphasys.com
5Buffer Solutions and Consumables
TypeUsage Based
Description

AmphaFluid buffer solutions (AF3 through AF11) and other consumables including AmphaCount and AmphaCalib for measurement preparation and calibration.

amphasys.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Pricing details1 tier
1Custom enterprise pricing based on instrument configuration and support package
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing available - all sales are quote-based. Support and maintenance contracts are available as separate annual plans.

amphasys.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Amphasys develops and manufactures impedance flow cytometry instruments and consumables for label-free, real-time single-cell analysis. Its product portfolio includes the Ampha Z40 (universal lab analyzer for pollen and cells >50μm), Ampha P20 (portable field pollen analyzer), and Ampha X30 (bioprocessing analyzer for cells 1–50μm), complemented by AmphaSoft PRO software, AmphaChip microfluidic consumables, and AmphaFluid buffer solutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 9000 pollen viability measurements per year conducted at a single tomato seed production site
+4 more records
Product overview1 text field

Amphasys offers a portfolio of impedance flow cytometry instruments for label-free single-cell analysis in the seed industry and bioprocessing. The product line centers on three main instruments: Ampha Z40 (universal laboratory analyzer for pollen and cells >50μm), Ampha P20 (portable field analyzer for on-site pollen testing), and Ampha X30 (bioprocessing analyzer for cells 1-50μm including yeast, bacteria, and mammalian cells). These instruments share the same underlying impedance flow cytometry technology platform and are supported by AmphaSoft PRO software for data analysis, AmphaChip microfluidic consumables (available as universal chips for all pollen types or crop-specific chips with automated protocols), and AmphaFluid buffer solutions. The ecosystem is designed for applications ranging from plant breeding and seed production to bioprocess monitoring and quality control.

Product and service7 records
1Ampha Z40
CategoryAnalytical Instruments
Description

Universal, flexible laboratory instrument for impedance-based cell analysis, specifically designed for cells larger than 50 μm such as pollen. Combines advanced cell viability research capabilities with high-throughput routine analysis for plant research, breeding, and seed production applications.

2Ampha P20
CategoryAnalytical Instruments
Description

Portable pollen analyzer providing laboratory-grade pollen viability and quantity measurements directly to the greenhouse, field, or production site. Compact, rugged, battery-powered design with touchscreen interface and automated data analysis for on-site decision-making.

3Ampha X30
CategoryAnalytical Instruments
Description

Stationary cell analyzer tailored for bioprocessing workflows, optimized for cells from 1 to 50 μm including yeast, bacteria, and mammalian cells. Provides real-time, label-free insights into cell viability, concentration, and metabolic activity even in turbid or complex media.

4AmphaSoft PRO
CategorySoftware
Description

Integrated software environment for structured pollen data evaluation, converting electrical impedance signals into interpretable scatterplots. Enables both fully automated data analysis and detailed individual interpretation with standardized evaluation settings.

5AmphaChip (Universal)
CategoryConsumables
Description

Universal microfluidic chips available in four channel sizes (80, 120, 250, 300 μm) compatible with Ampha Z40, providing full flexibility for research applications, user-defined gating strategies, and custom sampling protocols for analyzing pollen from all plants.

6AmphaChip (Crop-Specific)
CategoryConsumables
Description

Crop-specific microfluidic chips for automated pollen analysis, available for major crops including tomato, pepper, brassicas, cucurbits, corn, wheat, sunflower, onion, carrot, and beet. Predefined measurement parameters and automated data analysis without gating strategies required.

7AmphaFluid Series
CategoryConsumables
Description

Buffer solutions (AmphaFluid 3 through 11) for pollen sample preparation and measurement. Each formulation optimized for specific pollen types and measurement conditions.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

US-based drone technology company offering aerial pollination services to farmers. Uses Ampha Z32 for pollen quality control to ensure the right pollen is applied at the right time and place. Partnership enables supplementary pollination for fruit orchards using drone technology combined with Amphasys' pollen analysis.

Strategic tierCoreTypeTechnology or Integration
Description

Developed ChoViva, a sustainable chocolate alternative, and ChoViva butter through precision fermentation of oleaginous yeasts. Uses Amphasys impedance flow cytometry technology to optimize fermentation processes, achieving cocoa butter alternative that is 90% chemically identical to cocoa butter with over 90% reduction in greenhouse gas emissions and water usage.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global flow cytometry leader with the CytoFLEX, Navios, and Gallios platforms serving pharma, biotech, and academic customers. Amphasys competes in adjacent flow cytometry workflows but lacks the broad menu and global service network.

TypeBroad incumbent
Description

One of the two dominant flow cytometry players, with the BD FACSDiscover, LSRFortessa, and cell sorting portfolios. Comparable in product category (single-cell analysis instruments) but vastly broader in customer base and reagents.

TypeDirect peer
Description

Specialist flow cytometry company known for the Aurora spectral cell analyzer. Targets immunology, oncology, and bioprocess workflows with a more comprehensive cell analysis platform than Amphasys, but shares a similar instrument-sale + consumable economics.

TypeDirect peer
Description

Specialist in flow cytometry for sub-micron particles including bacteria, mitochondria, and viruses. Closest competitor to Amphasys' small-cell bioprocess applications with a comparable scale and product philosophy.

TypeDirect peer
Description

NucleoCounter line of cell counting and viability instruments used in cell therapy, bioprocess, and quality control. Competes with the Ampha X30 for routine cell counting/viability slots in bioprocess labs.

TypeBroad incumbent
Description

Provides the Seahorse metabolic analysis platform and cell analysis flow cytometry tools for pharma and biotech. Overlaps with Amphasys' bioprocess metabolic-status positioning, with much broader portfolio reach.

TypeBroad incumbent
Description

Flow cytometry instruments and reagents for clinical and research markets. Offers competing cell analysis platforms with broader menus, comparable in product category though different in target segments.

TypeEmerging player
Description

Microfluidic cell sorting and analysis tools using gentle, label-free approaches. Shares the microfluidic heritage with Amphasys and targets cell therapy and bioprocess workflows.

9Levitas Bio
TypeEmerging player
Description

Developer of label-free magnetic levitation cell analysis for life science research. Represents a competing label-free single-cell analysis approach that could overlap with impedance-based workflows.

TypeOthers
Description

Major bioprocess equipment and consumables supplier whose customer base (pharma and biotech manufacturers) overlaps directly with Amphasys' bioprocess users. Adjacent rather than directly competitive, but shapes bioprocess procurement decisions.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers14 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Amphasys

Analytical Laboratory Instrumentsamphasys.com

Amphasys AG, founded 2012 in Lucerne, Switzerland, develops impedance flow cytometry instruments for label-free single-cell analysis, serving plant breeding and seed production enterprises as well as bioprocessing and food technology customers with hardware, consumable chips, and software.

What Amphasys does

Amphasys AG is a Swiss specialty instrument company, founded in 2012 and headquartered at Technopark Lucerne, that develops and manufactures impedance flow cytometry (IFC) platforms for label-free, real-time single-cell analysis. Its core technology characterizes cells as they pass through microfluidic channels under alternating electrical fields, measuring cell size, membrane integrity, cytoplasmic conductivity, and metabolic status without dyes, markers, or calibration. The product line consists of three analyzers — the Ampha Z40 (stationary instrument for pollen and cells larger than 50 μm), the Ampha X30 (stationary instrument optimized for 1–50 μm cells in bioprocessing), and the Ampha P20 (portable battery-powered field analyzer) — supported by AmphaSoft PRO analysis software, patented microfluidic consumable chips (universal and crop-specific variants covering 250+ plant species), and AmphaFluid buffer solutions.

The company sells primarily to enterprise customers in the plant breeding and seed production industry (BASF, Bayer, Corteva, Syngenta, Rijk Zwaan, KWS, Bejo, Enza Zaden, Lidea Seeds, PanAmerican Seed), with growing penetration into industrial bioprocessing and food technology applications (Nestlé, Bühler, Doppelleu, Planet A Foods, edete Precision Technologies, Dropcopter) and academic research (University of Salzburg, University of Virginia, EPFL, RWTH Aachen). Revenue is generated through a mix of hardware sales, recurring consumable chip revenue, software, and service contracts, distributed via direct enterprise sales complemented by a global regional distributor network across Europe, North America, South America, Australia, and Africa.

Pricing is quote-based rather than publicly disclosed, consistent with enterprise sales of capital equipment plus multi-year service agreements. The company holds ISO 9001:2015 certification, supports 21 CFR Part 11-compliant workflows on the Ampha X30, and maintains community engagement through its annual Amphacademy symposium, which has run annually since 2017. No external equity funding rounds are disclosed, with only non-dilutive participation in MassChallenge (2020) and Technopark Luzern (2017) recorded, indicating an organic, self-funded growth profile across roughly 13 years of operation.

Amphasys firmographics

Firmographics
Name
Amphasys
Legal name
Amphasys AG
Website
https://amphasys.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
Amphasys AG, founded 2012 in Lucerne, Switzerland, develops impedance flow cytometry instruments for label-free single-cell analysis, serving plant breeding and seed production enterprises as well as bioprocessing and food technology customers with hardware, consumable chips, and software.
Ownership category
akta.pro rank

Amphasys industry classification

Industry
Product category
Analytical Laboratory Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
SECONDARYHLAAAJAC
Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Impedance flow cytometry
  • Label-free cell analysis
  • Pollen viability testing
  • Bioprocess monitoring
  • Single-cell analysis instruments

Where Amphasys is headquartered

Location

Headquarters

HQ city
Lucerne
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

Amphasys business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Hardware Sales - Impedance Flow Cytometers: Sale of Ampha X30, Ampha Z40, and Ampha P20 instruments - the core impedance flow cytometry hardware platforms for cell and pollen analysis.
  2. Microfluidic Chips (AmphaChip): Recurring consumable revenue from universal and crop-specific microfluidic chips. Universal chips come in 4 sizes; crop-specific chips available for major crops. Each chip provides 1000 measurements.
  3. Software Licenses and Subscriptions: AmphaSoft PRO software for data analysis. The software is integrated with the instrument platform and supports both automated routine analysis and in-depth research analysis.
  4. Support and Maintenance Contracts: Annual support and maintenance plans for instruments including software updates, technical support, and calibration services. Separate service contracts available for Ampha P20 and Ampha Z32/Z40 instruments.
  5. Buffer Solutions and Consumables: AmphaFluid buffer solutions (AF3 through AF11) and other consumables including AmphaCount and AmphaCalib for measurement preparation and calibration.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom enterprise pricing based on instrument configuration and support package

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Amphasys product offering

Product offering

Core offering

Amphasys develops and manufactures impedance flow cytometry instruments and consumables for label-free, real-time single-cell analysis. Its product portfolio includes the Ampha Z40 (universal lab analyzer for pollen and cells >50μm), Ampha P20 (portable field pollen analyzer), and Ampha X30 (bioprocessing analyzer for cells 1–50μm), complemented by AmphaSoft PRO software, AmphaChip microfluidic consumables, and AmphaFluid buffer solutions.

Product overview

Amphasys offers a portfolio of impedance flow cytometry instruments for label-free single-cell analysis in the seed industry and bioprocessing. The product line centers on three main instruments: Ampha Z40 (universal laboratory analyzer for pollen and cells >50μm), Ampha P20 (portable field analyzer for on-site pollen testing), and Ampha X30 (bioprocessing analyzer for cells 1-50μm including yeast, bacteria, and mammalian cells). These instruments share the same underlying impedance flow cytometry technology platform and are supported by AmphaSoft PRO software for data analysis, AmphaChip microfluidic consumables (available as universal chips for all pollen types or crop-specific chips with automated protocols), and AmphaFluid buffer solutions. The ecosystem is designed for applications ranging from plant breeding and seed production to bioprocess monitoring and quality control.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ampha Z40 Universal, flexible laboratory instrument for impedance-based cell analysis, specifically designed for cells larger than 50 μm such as pollen. Combines advanced cell viability research capabilities with high-throughput routine analysis for plant research, breeding, and seed production applications.
  • Ampha P20 Portable pollen analyzer providing laboratory-grade pollen viability and quantity measurements directly to the greenhouse, field, or production site. Compact, rugged, battery-powered design with touchscreen interface and automated data analysis for on-site decision-making.
  • Ampha X30 Stationary cell analyzer tailored for bioprocessing workflows, optimized for cells from 1 to 50 μm including yeast, bacteria, and mammalian cells. Provides real-time, label-free insights into cell viability, concentration, and metabolic activity even in turbid or complex media.
  • AmphaSoft PRO Integrated software environment for structured pollen data evaluation, converting electrical impedance signals into interpretable scatterplots. Enables both fully automated data analysis and detailed individual interpretation with standardized evaluation settings.
  • AmphaChip (Universal) Universal microfluidic chips available in four channel sizes (80, 120, 250, 300 μm) compatible with Ampha Z40, providing full flexibility for research applications, user-defined gating strategies, and custom sampling protocols for analyzing pollen from all plants.
  • AmphaChip (Crop-Specific) Crop-specific microfluidic chips for automated pollen analysis, available for major crops including tomato, pepper, brassicas, cucurbits, corn, wheat, sunflower, onion, carrot, and beet. Predefined measurement parameters and automated data analysis without gating strategies required.
  • AmphaFluid Series Buffer solutions (AmphaFluid 3 through 11) for pollen sample preparation and measurement. Each formulation optimized for specific pollen types and measurement conditions.

Quantifiable outcome

  • 9000 pollen viability measurements per year conducted at a single tomato seed production site
  • +4 more outcomes

Companies that use Amphasys

Customer profile

Named customers14 records

Segments3 records

Ideal customer profiles3 records

Amphasys technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Amphasys partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • DropcoptercoreStrategic or Co-development PartnerUS-based drone technology company offering aerial pollination services to farmers. Uses Ampha Z32 for pollen quality control to ensure the right pollen is applied at the right time and place. Partnership enables supplementary pollination for fruit orchards using drone technology combined with Amphasys' pollen analysis.
  • Planet A FoodscoreTechnology or IntegrationDeveloped ChoViva, a sustainable chocolate alternative, and ChoViva butter through precision fermentation of oleaginous yeasts. Uses Amphasys impedance flow cytometry technology to optimize fermentation processes, achieving cocoa butter alternative that is 90% chemically identical to cocoa butter with over 90% reduction in greenhouse gas emissions and water usage.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Amphasys competitors and assessment

Company assessment

Broad incumbents

  • Beckman Coulter Life Sciences (Danaher): Global flow cytometry leader with the CytoFLEX, Navios, and Gallios platforms serving pharma, biotech, and academic customers. Amphasys competes in adjacent flow cytometry workflows but lacks the broad menu and global service network.
  • BD Biosciences: One of the two dominant flow cytometry players, with the BD FACSDiscover, LSRFortessa, and cell sorting portfolios. Comparable in product category (single-cell analysis instruments) but vastly broader in customer base and reagents.
  • Agilent Technologies (Cell Analysis): Provides the Seahorse metabolic analysis platform and cell analysis flow cytometry tools for pharma and biotech. Overlaps with Amphasys' bioprocess metabolic-status positioning, with much broader portfolio reach.
  • Sysmex Partec: Flow cytometry instruments and reagents for clinical and research markets. Offers competing cell analysis platforms with broader menus, comparable in product category though different in target segments.

Direct peers

  • Cytek Biosciences: Specialist flow cytometry company known for the Aurora spectral cell analyzer. Targets immunology, oncology, and bioprocess workflows with a more comprehensive cell analysis platform than Amphasys, but shares a similar instrument-sale + consumable economics.
  • Apogee Flow Systems: Specialist in flow cytometry for sub-micron particles including bacteria, mitochondria, and viruses. Closest competitor to Amphasys' small-cell bioprocess applications with a comparable scale and product philosophy.
  • Chemometec: NucleoCounter line of cell counting and viability instruments used in cell therapy, bioprocess, and quality control. Competes with the Ampha X30 for routine cell counting/viability slots in bioprocess labs.

Emerging players

  • NanoCellect Biomedical: Microfluidic cell sorting and analysis tools using gentle, label-free approaches. Shares the microfluidic heritage with Amphasys and targets cell therapy and bioprocess workflows.
  • Levitas Bio: Developer of label-free magnetic levitation cell analysis for life science research. Represents a competing label-free single-cell analysis approach that could overlap with impedance-based workflows.

Others

  • Sartorius: Major bioprocess equipment and consumables supplier whose customer base (pharma and biotech manufacturers) overlaps directly with Amphasys' bioprocess users. Adjacent rather than directly competitive, but shapes bioprocess procurement decisions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Amphasys social profiles

Digital presence

Amphasys compliance and trust

Trust signal

Compliance2 records

Amphasys financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Amphasys leadership team

Management profile

Number of profiles

Profiles9 records

Amphasys funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Amphasys M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amphasys

What does Amphasys do?

Amphasys develops and manufactures impedance flow cytometry instruments and consumables for label-free, real-time single-cell analysis. Its product portfolio includes the Ampha Z40 (universal lab analyzer for pollen and cells >50μm), Ampha P20 (portable field pollen analyzer), and Ampha X30 (bioprocessing analyzer for cells 1–50μm), complemented by AmphaSoft PRO software, AmphaChip microfluidic consumables, and AmphaFluid buffer solutions.

Is Amphasys a public or private company?

Amphasys is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Amphasys founded?

Amphasys was founded in 2012. It employs 11 to 50 people.

Where is Amphasys based?

Amphasys is headquartered in Lucerne, Switzerland, in the Europe region.

How does Amphasys make money?

Five revenue lines are on record. Hardware Sales - Impedance Flow Cytometers are the primary driver. The others are microfluidic Chips (AmphaChip), software Licenses and Subscriptions, support and Maintenance Contracts and buffer Solutions and Consumables.

Who are Amphasys's main competitors?

Broad incumbents on record are Beckman Coulter Life Sciences (Danaher), BD Biosciences, Agilent Technologies (Cell Analysis) and Sysmex Partec. Direct peers are Cytek Biosciences, Apogee Flow Systems and Chemometec. Emerging players are NanoCellect Biomedical and Levitas Bio. Sartorius is listed as an others.

Does Amphasys have an API?

No public API is recorded for Amphasys.

What industry is Amphasys in?

Amphasys's product category is Analytical Laboratory Instruments. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals